
HMS Holdings Corp. EBITDA 2011-2026 | HMSY
Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]
EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.
EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.
However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.
Annual EBITDA HMS Holdings Corp.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 140 M | 146 M | 141 M | 101 M | 103 M | 98.2 M | 87.8 M | 135 M | 154 M | 103 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 154 M | 87.8 M | 121 M |
References
- Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.
EBITDA of other stocks in the Health information services industry
| Issuer | EBITDA | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
-38.6 M | - | 0.29 % | $ 206 M | ||
|
Cerner Corporation
CERN
|
1.43 B | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
-40.7 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
148 M | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
-5.95 M | - | -7.28 % | $ 227 M | ||
|
Inovalon Holdings, Inc.
INOV
|
187 M | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
-6.03 M | - | - | $ 102 M | ||
|
1Life Healthcare
ONEM
|
-197 M | - | - | $ 3.37 B | ||
|
Akerna Corp.
KERN
|
-6.57 M | - | - | $ 161 M | ||
|
HealthStream
HSTM
|
62.5 M | $ 22.03 | 1.52 % | $ 669 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
253 M | - | -10.39 % | $ 886 M | ||
|
American Well Corporation
AMWL
|
-71.3 M | $ 5.56 | 7.96 % | $ 89.2 M | ||
|
Evolent Health
EVH
|
70.8 M | $ 3.55 | 1.28 % | $ 333 M | ||
|
HealthEquity
HQY
|
271 M | $ 81.45 | 1.27 % | $ 6.97 B | ||
|
MTBC
MTBC
|
23.3 M | - | -0.58 % | $ 51.7 M | ||
|
Change Healthcare
CHNG
|
691 M | - | - | $ 9.03 B | ||
|
Omnicell
OMCL
|
82.6 M | $ 41.51 | 1.73 % | $ 1.91 B | ||
|
GoodRx Holdings
GDRX
|
135 M | $ 2.19 | 5.8 % | $ 845 M | ||
|
Health Catalyst
HCAT
|
-28.4 M | $ 1.94 | 12.79 % | $ 117 M | ||
|
Progyny
PGNY
|
19 M | $ 17.95 | 2.43 % | $ 1.54 B | ||
|
Premier
PINC
|
119 M | - | - | $ 2.33 B | ||
|
So-Young International
SY
|
-579 M | $ 2.89 | 3.96 % | $ 229 M | ||
|
R1 RCM
RCM
|
223 M | - | - | $ 3.81 B | ||
|
NantHealth
NH
|
-35.3 M | - | -46.64 % | $ 10.4 M | ||
|
OptimizeRx Corporation
OPRX
|
-24 M | $ 7.94 | 8.47 % | $ 136 M | ||
|
NextGen Healthcare
NXGN
|
20.8 M | - | - | $ 1.6 B | ||
|
Phreesia
PHR
|
-107 M | $ 12.67 | 2.34 % | $ 691 M | ||
|
Schrödinger
SDGR
|
-161 M | $ 13.17 | 5.32 % | $ 967 M | ||
|
Zhongchao
ZCMD
|
-110 K | $ 1.69 | -1.98 % | $ 8.8 M | ||
|
Signify Health
SGFY
|
63.3 M | - | -0.02 % | $ 7.21 B | ||
|
Teladoc Health
TDOC
|
87.8 M | $ 5.2 | 1.76 % | $ 916 M | ||
|
Streamline Health Solutions
STRM
|
-3.18 M | - | - | $ 21.4 M | ||
|
10x Genomics
TXG
|
-230 M | $ 22.46 | -0.73 % | $ 2.63 B | ||
|
Tabula Rasa HealthCare
TRHC
|
-45.6 M | - | - | $ 255 M | ||
|
Veeva Systems
VEEV
|
435 M | $ 188.53 | 1.38 % | $ 30.3 B | ||
|
SCWorx Corp.
WORX
|
-1.26 M | $ 0.14 | -19.22 % | $ 204 K |